Table:
begin	end	state
1	32	cytoplasmic
33	56	transmembrane
57	66	non-cytoplasmic
67	91	transmembrane
92	105	cytoplasmic
106	134	transmembrane
135	167	non-cytoplasmic
168	186	transmembrane
187	196	cytoplasmic
197	217	transmembrane
218	236	non-cytoplasmic
237	256	transmembrane
257	275	cytoplasmic
276	301	transmembrane
302	320	non-cytoplasmic
321	343	transmembrane
344	372	cytoplasmic
373	392	transmembrane
393	397	non-cytoplasmic
398	417	transmembrane
418	429	cytoplasmic
430	450	transmembrane
451	455	non-cytoplasmic
456	475	transmembrane
476	481	cytoplasmic

Input:
>WP_102938052.1 NCBI__GCF_002117405.1:WP_102938052.1
MLTRSRSVYFSRKSIHLVIAENDAEENGLKRALGWASLMAMGIGGIIGAGIFVLTGQAAA
DYAGPGVTISFLLSGLACTFVALCYAELAALIPAAGSTYTYTYVTLGEIFAWIIGWNLVL
EYAAGAATVAVGWAGYFNRVMQGLGIHLPEALTSAYFANAHSIGGTHGVFNVPAAAIILL
LTALLMRGTSESSFFNNIIVVIKVMVVLVVIFVGAAHVDAANWTPLIPENTDHFGHFGWS
GVVRGASVVFFAYIGFDGVSTAAQEAHTPQRDVPIGILGSLVICTILYVAVAAVATGVVS
YKELGVPDPMALVMDRTGVAWLSWVVKLGAIAGLTTAILLLLFGQTRIFYAMAQDGLLPK
VFAAVHPVWRTPAVSQALVGVFVALAAGLFPINILDEMVSIGTLAAFALVCGAVLHLRRS
QPDMHRPFRAPGIPAMPLLGIASCLALMVALPLETWLRLIVWTAIGMAIYFFYGVKHAKR
A

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server